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Background:  Anticoagulation therapy is time intensive for patients and health care providers. Previous studies have determined that patient self-
testing of INR improves safety and effectiveness. We evaluated a novel home PT/INR wireless communication system that allows for bidirectional 
communication between patient and health care provider of clinical questionnaire, fingerstick INR result, warfarin dose, and dose confirmation. 
Methods:  Randomized open label crossover trial comparing standard INR management (lab-based INR with warfarin dosing by telephone) versus 
the home wireless communication system. Patients requiring long-term oral anticoagulation (goal INR 2-3) who had been followed in a single-center 
Coumadin clinic for > 3 months were included. Patients were assessed at baseline and at the end of each of two 12-week periods. During the home 
monitoring period, INR was tested weekly. INR was tested at least every 3 weeks during the standard care period. 
Results:  N=25 patients were enrolled. Mean age 53.7 + 11.7 years and 60% (15/25) were male. Indication for anticoagulation was venous 
thromboembolism in 92% of patients (23/25). The use of the home monitoring system was time saving for patients (19.4 + 2.3 minutes per 
encounter vs. 47.0 + 2.6 minutes, P<0.01) and nurses (3.8 + 0.2 minutes vs. 6.8 + 0.3 minutes, P<0.01) and was associated with fewer telephone 
contacts per encounter for patients (0.38+0.07 vs. 1.12+0.07, P<0.01) and nurses (0.41+0.04 vs. 1.03 +0.04, P<0.01). Median of 66.7% of INR 
encounters per patient (IQR 46.2-69.2%) were performed using the home system without telephone communication with the Coumadin clinic. There 
were no statistically significant differences in % INR within therapeutic range, patient satisfaction (PSQ-18, DASS) or quality of life scales (VR-12) in 
this pilot study, however, 82.6% of participants reported that the home system made management of Coumadin easier and/or saved their time.
Conclusions:  The use of a novel home PT/INR wireless communication system was feasible and time saving for patients and health care 
providers. Larger studies of this technology should assess its effect on % INR within therapeutic range, cost efficacy, and quality of life.
